Print    Email
Decrease (-) Restore Default Increase (+)

News

Title
First Hospital in Iowa to Implant S-ICD for Patients at Risk of Sudden Cardiac Arrest
Start Date
03/10/2014
Article

Mason City, IA (January 31, 2014) -- On Monday, January 20, Mercy Medical Center – North Iowa became the first hospital in Iowa to implant a subcutaneous implantable defibrillator (S-ICD). An implantable defibrillator is used for the treatment of patients at risk for sudden cardiac arrest.

The S-ICD System is designed to provide the same protection from SCA as transvenous implantable cardioverter defibrillators (ICDs); however the S-ICD System sits entirely just below the skin without the need for thin, insulated wires – known as electrodes or ‘leads’ – to be placed into the heart itself. This leaves the heart and blood vessels untouched, offering physicians and patients an alternative treatment to transvenous ICDs. The S-ICD device is used in very specific situations and must meet medical criteria to be implanted. ICD devices cannot be used for all patients with risk for cardolshanski.bryan.jpgiac arrest. This device does not include a pace maker.

The procedure was performed by Brian Olshansky, M.D., Electrophysiologist, and Mark Mulkey, M.D., Plastic Surgeon.

“The new S-ICD System provides implanting physicians with a new breakthrough treatment option for patients at risk of sudden cardiac arrest,” said Brian Olshansky, M.D., at Mercy Medical Center – North Iowa. “The system’s innovative design is an important new alternative that provides patients with a new treatment option that eliminates the need for transvenous leads.”

Sudden cardiac arrest is an abrupt loss of heart function. Most episodes are caused by the rapid and/or chaotic activity of the heart known as ventricular tachycardia or ventricular fibrillation. Recent estimates show that approximately 850,000 people in the United States are at risk of SCA and indicated for an ICD device, but remain unprotected.

Mercy Medical Center – North Iowa has used implantable defibrillators for many years, however, this is the first one that does not involve more invasive surgery for implantation.

Dr. Olshansky is a world-renowned Electrophysiologist who now practices medicine at the Mercy Heart and Vascular Institute. Dr. Olshansky’s research has focused on the treatment for anMulkey2014.jpgd mechanism of atrial and ventricular arrhythmias. He has been involved in numerous clinical trials, and has published over 170 peer-reviewed manuscripts (a total of over 400 total publications, including non-peer-reviewed manuscripts, reviews, e-publications, slide series and editorials), over 210 abstracts, over 40 chapters and three books: Syncope-Mechanisms and Management (and a second edition) and Arrhythmia Essentials. He is, or has been, a member of over 20 editorial boards, reviewed regularly for three NIH study sections for over 10 years, reviews for over 65 medical journals (an Elite Reviewer for the Journal of the American College of Cardiology) and has been on several event committees. He has been a guest editor and managing editor of several journals. He is a speaker with diverse and extensive experience.

Dr. Mark Mulkey is a member of the Mason City Clinic in the Department of Plastic Surgery. Dr. Mulkey performs the following procedures at Mercy Medical Center - North Iowa: Hand surgeries such as, carpel tunnel, ganglion, trigger finger and congenital deformities; reconstructive surgeries such as breast cancer reconstruction, burn care, skin cancer excisions and reconstruction, complex wound care; and cosmetic surgeries such as breast augmentation, mastopexy (breast lift), body lift, abdominoplasty, thigh lift, brachioplasty (arm lift), rhytidectomy (face lift), otoplasty, rhinoplasty, brow lift, blepharoplasty, Botox, Radiesse, and Juvéderm treatments, hair removal and liposuction.

©  2014 

 Mercy Medical Center-North Iowa | 1000 4th Street SW Mason City, IA 50401 | 641-428-7000

                                   Follow Me on Pinterest   Google+